PODCAST-19: FiveThirtyEight on the Novel Coronavirus
Podcast készítő FiveThirtyEight, Anna Rothschild
46 Epizód
-
How To Vote Safely In A Pandemic
Közzétéve: 2020. 10. 29. -
Would Biden’s COVID-19 Plan Be Able To Control The Pandemic?
Közzétéve: 2020. 10. 16. -
The President Took A Rare Combo Of COVID-19 Drugs. Will It Help?
Közzétéve: 2020. 10. 07. -
The Significance Of Trump Testing Positive For COVID-19
Közzétéve: 2020. 10. 02. -
The New College Experience
Közzétéve: 2020. 09. 26. -
Can We Trust A Vaccine That Gets Approved?
Közzétéve: 2020. 09. 19. -
Why A Vaccine Trial Would Press Pause
Közzétéve: 2020. 09. 12. -
The U.S. Wants Out Of A Global Effort To Stop A Global Pandemic
Közzétéve: 2020. 09. 04. -
What's It Going To Take For Us To Become Immune?
Közzétéve: 2020. 08. 28. -
Russia Approved A COVID Vaccine. Will It Be Available In America?
Közzétéve: 2020. 08. 14. -
PODCAST-19 Has The Week Off!
Közzétéve: 2020. 08. 07. -
Lab-Grown Antibodies Might Protect Essential Workers
Közzétéve: 2020. 07. 31. -
It's Harder to Get A COVID Test If You're Black Or Hispanic
Közzétéve: 2020. 07. 24. -
When Does A Pandemic Start To Erode Civil Liberties?
Közzétéve: 2020. 07. 17. -
Dr. Anthony Fauci Talks With PODCAST-19
Közzétéve: 2020. 07. 09. -
How To Convince People To Stop A Pandemic
Közzétéve: 2020. 07. 03. -
Do Masks Actually Work?
Közzétéve: 2020. 06. 26. -
Who Will Be First To Get A COVID Vaccine?
Közzétéve: 2020. 06. 19. -
The Case Of The Bogus Hydroxycholoroquine Study
Közzétéve: 2020. 06. 12. -
What It's Like To Be A Black Doctor And Nurse Right Now
Közzétéve: 2020. 06. 05.
FiveThirtyEight's COVID-19 podcast is laser-focused on evidence. What do we know about the novel coronavirus, and what do we know we don't know? COVID-19 has pushed Americans into more uncertain territory than most have ever known. Our podcast helps listeners understand what they can be certain about, and what is still unknown. We investigate coronavirus mysteries, debate when it's safe to reopen the economy and keep track of the latest scientific developments on vaccines and treatments. We do it all with FiveThirtyEight's trademark blend of transparency and rigor.
